Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:15 PM
Ignite Modification Date:
2026-03-26 @ 3:15 PM
NCT ID:
NCT07459192
Eligibility Criteria:
Inclusion Criteria:
* Age over 18 years, gender not restricted;
* patients with malignant tumors confirmed by biopsy or surgical pathology;
* Imaging findings of suspicious lymph nodes or distant metastases;
* informed consent signed in writing by the subject or his/her legal guardian.
Exclusion Criteria:
* patients who have received antitumor therapy prior to PET/CT or PET/MR scanning;
* Patients with severe medical conditions who cannot tolerate PET/CT or PET/MR scans;
* The alternative subjects have contraindications to PET/CT or PET/MR scans;
* exposure to radiation of more than 50 mSv in the past year;
* The alternative subjects underwent major surgery within the past 3 months; received experimental drug or device therapy (with unclear efficacy or safety) within the past 1 month;
* The alternative subjects had any clinical conditions that the principal investigator of this study considered to be potentially harmful or associated with the formulation.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07459192
Study Brief:
Protocol Section:
NCT07459192